Paramedic Papers

Home Cardiac arrest Amiodarone after non-shockable-to-shockable conversion

Cardiac arrest

Amiodarone after non-shockable-to-shockable conversion

Amiodarone After Conversion From a Non-shockable to a Shockable Rhythm in Out-of-Hospital Cardiac Arrest A Propensity Score-Matched Analysis from the German Resuscitation Registry
Resuscitation · 2026-10 · Added 8 October 2026

German Resuscitation Registry propensity-matched cohort testing whether amiodarone helps OHCA patients whose initial non-shockable rhythm converts to shockable — it was associated with better 24-hour and survival-to-discharge, though not clearly better neurological outcome.

Study type
Registry
Design
Propensity-score-matched retrospective registry cohort
Participants
5,535 adults with non-traumatic OHCA (1,843 matched pairs)
Main finding
Amiodarone was associated with higher admission with ROSC (26.7% vs 23.0%; OR 1.22), 24-hour survival (21.4% vs 14.7%; OR 1.58) and survival to discharge (6.5% vs 4.2%; OR 1.58), but favourable neurological outcome was not statistically significant (3.7% vs 2.9%; OR 1.31, 95% CI 0.91-1.89)
Caveat
Retrospective registry data with residual confounding despite matching — the neurologically intact survival signal didn't reach significance, so this is association, not proof
Bottom line
Hypothesis-generating

Why it matters in Australia (High relevance). Amiodarone is standard in Australian cardiac arrest care, and rhythm conversion mid-arrest is exactly the scenario crews wonder about dosing — this is directly on-guideline territory.

Learning goal

Weigh the benefits of amiodarone when a non-shockable rhythm converts to shockable during cardiac arrest resuscitation.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Cardiac arrest